This report provides a review of international experience to draw out practical and scientific approaches for both the Ministry of Health (MOH) and Vietnam Social Security (VSS) to consider. Conclusions and recommendations are provided.

Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.

Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.

This brief shares insights from LHSS’s review of Timor-Leste’s thriving landscape of civil society organizations (CSOs), with a focus on those that are active in the health sector.

LHSS shared the review of Timor-Leste’s thriving landscape of civil society organizations (CSOs), with a focus on those that are active in the health sector.

This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.

This report summarizes the results of a review of international experience and best practices related to pro-health excise taxes.

LHSS in this report recommends that the government raise pro-health excise taxes at greater rates than currently proposed by the Ministry of Finance in order to increase the revenue raised.

This report offers recommendations to strengthen engagement mechanisms and increase CSOs’ and community awareness of health services and citizens’ rights.

LHSS Vietnam works to strengthen the Government of Vietnam’s capacity to sustainably manage holistic HIV and TB programs that will drive achievement of the country’s commitment to end HIV and TB by 2030.